Advertisement
Canada markets open in 4 hours 21 minutes
  • S&P/TSX

    22,375.83
    +116.63 (+0.52%)
     
  • S&P 500

    5,214.08
    +26.41 (+0.51%)
     
  • DOW

    39,387.76
    +331.36 (+0.85%)
     
  • CAD/USD

    0.7309
    -0.0002 (-0.03%)
     
  • CRUDE OIL

    79.60
    +0.34 (+0.43%)
     
  • Bitcoin CAD

    86,073.90
    +2,297.81 (+2.74%)
     
  • CMC Crypto 200

    1,303.89
    -54.12 (-3.98%)
     
  • GOLD FUTURES

    2,376.70
    +36.40 (+1.56%)
     
  • RUSSELL 2000

    2,073.63
    +18.49 (+0.90%)
     
  • 10-Yr Bond

    4.4490
    -0.0430 (-0.96%)
     
  • NASDAQ futures

    18,289.25
    +74.75 (+0.41%)
     
  • VOLATILITY

    12.77
    +0.08 (+0.63%)
     
  • FTSE

    8,432.66
    +51.31 (+0.61%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • CAD/EUR

    0.6777
    -0.0001 (-0.01%)
     

What Analysts Think about Aphria in November

What Analysts Think about Aphria in November

Aphria (APHQF) has had one of the weakest months compared to other cannabis companies (HMMJ) such as Canopy Growth (WEED), Supreme Cannabis (SPRWF), and HEXO (HEXO). In this month alone, the stock has declined by nearly 21.4%. Let’s look at what analysts think.